Cargando…

The Relationship between Pathological Features and (18) F-FDG PET/CT that Changed the Surgeon's Decision as Neoadjuvant Therapy in Breast Cancer

Objective Patients diagnosed with breast cancer and decided to undergo surgical treatment can undergo neoadjuvant therapy following their 2-deoxy-2-[fluorine-18]fluoro-D-glucose positron emission tomography/computed tomography ( (18) F-FDG PET/CT) findings. The present study aims to determine the s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Edizsoy, Akay, Dağ, Ahmet, Özcan, Pınar Pelin, Koç, Zehra Pınar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2022
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296238/ https://www.ncbi.nlm.nih.gov/pubmed/35865151 http://dx.doi.org/10.1055/s-0042-1750335

Ejemplares similares

Metabolic Characterization of Anterior Mediastinal Masses by (18)F-FDG PET/CT
por: Koç, Zehra Pınar, et al.
Publicado: (2020)

The Role of (18)F-FDG PET/CT in Detecting Ovarian Cancer Recurrence in Patients with Elevated CA-125 Levels
por: Cengiz, Arzu, et al.
Publicado: (2019)

Splenosis Mimicking Lymphoma Relapse Confirmed by (18)F-FDG PET/CT and Tc-99m Nano-colloid Scintigraphy Thirty Years After Splenectomy for Trauma
por: Koç, Zehra Pınar, et al.
Publicado: (2019)

Superscan Appearance of (68)Ga PSMA PET/CT in a Patient with Refractory Prostate Cancer
por: Koç, Zehra Pınar, et al.
Publicado: (2022)

Detection of unknown primary tumor in patients presented with brain metastasis by F-18 fluorodeoxyglucose positron emission tomography/computed tomography
por: Koç, Zehra Pınar, et al.
Publicado: (2018)

Cancers and Benign Processes on (68) Ga PSMA PET-CT Imaging Other than Prostate Cancer
por: Ozcan, Pinar Pelin, et al.
Publicado: (2022)

F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Images of Severe Primary Lung Lymphoma
por: Koç, Zehra Pınar, et al.
Publicado: (2020)

Lymphoblastic Involvement of the Bone Marrow as a Cause of Superscan Appearance in (18)F-Fluorodeoxyglucose Positron Emission Tomography/ Computed Tomography
por: Koç, Zehra Pınar, et al.
Publicado: (2020)

Volumetric Evaluation of Staging (18)F-FDG PET/CT Images in Patients with Esophageal Cancer
por: Karahan Şen, Nazlı Pınar, et al.
Publicado: (2022)

Askin's Tumor in an Adult: Case Report and Findings on 18F-FDG PET/CT
por: Kara Gedik, Gonca, et al.
Publicado: (2009)

Value of Dynamic (18)F-FDG PET/CT in Predicting the Success of Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer: A Prospective Study
por: Kupik, Osman, et al.
Publicado: (2023)

Amyloidosis Associated Kidney Failure with Gross Hypermetabolic Intra-abdominal Mass
por: Koç, Zehra Pınar, et al.
Publicado: (2020)

(18)F-FDG PET-CT after Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients to Optimize Surgical Decision Making
por: Anderegg, Maarten C. J., et al.
Publicado: (2015)

(18)F‐FDG PET/CT predicts the role of neoadjuvant immunochemotherapy in the pathological response of esophageal squamous cell carcinoma
por: Wang, Shuohua, et al.
Publicado: (2023)

Rare Thyroid Cartilage and Diaphragm Metastases from Lung Cancer Visualized on F-18 FDG-PET/CT Imaging
por: Özcan Kara, Pelin, et al.
Publicado: (2011)

Baseline 18F-FDG PET/CT as predictor of the pathological response to neoadjuvant therapy in esophageal cancer: A retrospective study
por: Domachevsky, Liran, et al.
Publicado: (2018)

Prognostic value of (18)F-FDG PET/CT parameters and histopathologic variables in head and neck cancer
por: Aslan, Hale, et al.
Publicado: (2019)

Thyroid incidentalomas on 18FDG-PET/CT: a metabolico-pathological correlation
por: Hagenimana, N., et al.
Publicado: (2017)

Colonic Malignant Melanoma: (18)F-FDG PET/CT Findings
por: Kaya, Eser, et al.
Publicado: (2018)

Assessment of response to neoadjuvant radiochemotherapy with F-18 FLT and F-18 FDG PET/CT in patients with rectal cancer
por: Rendl, Gundula, et al.
Publicado: (2014)

Minimal Invasive Radioguided Ectopic Parathyroidectomy in Upper Mediastinum
por: Koç, Zehra Pınar, et al.
Publicado: (2019)

The efficacy of (18)F-FDG PET/CT in the preoperative evaluation of pancreatic lesions
por: Akcam, Atilgan Tolga, et al.
Publicado: (2020)

Spectrum of [(18)F]FDG-PET/CT Findings in Benign Lymph Node Pathology
por: Zeman, Merissa N., et al.
Publicado: (2021)

Can Radiomics Analyses in (18)F-FDG PET/CT Images of Primary Breast Carcinoma Predict Hormone Receptor Status?
por: Araz, Mine, et al.
Publicado: (2022)

Giant Abdominal Lipoma in Adult
por: Cinar Ozcan, Nihal, et al.
Publicado: (2021)

Dynamic (18)F‐FDG PET/CT can predict the major pathological response to neoadjuvant immunotherapy in non‐small cell lung cancer
por: Chen, Zhi‐Yong, et al.
Publicado: (2022)

(18)F-FDG PET/CT imaging and PET-guided biopsy in evaluation and treatment decision in adrenal histoplasmosis
por: Kalathoorakath, Renjith Radhakrishnan, et al.
Publicado: (2016)

(18)F-FDG PET/CT Imaging In Oncology
por: Almuhaideb, Ahmad, et al.
Publicado: (2011)

Scar Sarcoidosis on (18)F-FDG PET/CT
por: Arora, Saurabh, et al.
Publicado: (2019)

18F-FDG PET/CT and COVID-19
por: Joob, Beuy, et al.
Publicado: (2020)

Influence of [(18)F]FDG-PET/CT on Clinical Management Decisions in Breast Cancer Patients—A PET/CT Registry Study
por: Werner, Sebastian, et al.
Publicado: (2023)

(18)F-FDG PET/CT Metrics Are Correlated to the Pathological Response in Esophageal Cancer Patients Treated With Induction Chemotherapy Followed by Neoadjuvant Chemo-Radiotherapy
por: Simoni, Nicola, et al.
Publicado: (2020)

Comments on “dynamic (18)F‐FDG PET/CT can predict the major pathological response to neoadjuvant immunotherapy in non‐small cell lung cancer”
por: Wang, Shan‐Ying, et al.
Publicado: (2022)

Prediction of prognosis and pathologic grade in follicular lymphoma using (18)F-FDG PET/CT
por: Li, Hongyan, et al.
Publicado: (2022)

Prognostic Prediction of BRCA Mutations by (18)F-FDG PET/CT SUV(max) in Breast Cancer
por: Özdemir, Semra, et al.
Publicado: (2021)

Measurement Repeatability of (18)F-FDG PET/CT Versus (18)F-FDG PET/MRI in Solid Tumors of the Pelvis
por: Fraum, Tyler J., et al.
Publicado: (2019)

Prediction and diagnosis of interval metastasis after neoadjuvant chemoradiotherapy for oesophageal cancer using (18)F-FDG PET/CT
por: Goense, Lucas, et al.
Publicado: (2018)

Monitoring tumor response to neoadjuvant chemotherapy using MRI and (18)F-FDG PET/CT in breast cancer subtypes
por: Schmitz, Alexander M. Th., et al.
Publicado: (2017)

Early Assessment of Response to Neoadjuvant Chemotherapy with (18)F-FDG-PET/CT in Patients with Advanced-Stage Ovarian Cancer
por: Chung, Young Shin, et al.
Publicado: (2020)

Predicting Response to Neoadjuvant Chemotherapy Using 18F FDG PET-CT in Patients with Locally Advanced Breast Cancer
por: Hulikal, Narendra, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ccmbu8v7h26keu4pavof4h9ujf